231 related articles for article (PubMed ID: 2559009)
21. [Symptomatic adrenoleukodystrophy heterozygote with fluctuated neurological symptoms--a case report].
Matsumuro K; Kuriyama M; Yoshida Y; Okatsu Y; Osame M
Rinsho Shinkeigaku; 1991 Aug; 31(8):872-4. PubMed ID: 1764863
[TBL] [Abstract][Full Text] [Related]
22. The adrenoleukodystrophies.
Moser HW; Naidu S; Kumar AJ; Rosenbaum AE
Crit Rev Neurobiol; 1987; 3(1):29-88. PubMed ID: 3552451
[TBL] [Abstract][Full Text] [Related]
23. Reproductive function in men affected by X-linked adrenoleukodystrophy/adrenomyeloneuropathy.
Stradomska TJ; Kubalska J; Janas R; Tylki-Szymanska A
Eur J Endocrinol; 2012 Feb; 166(2):291-4. PubMed ID: 22048970
[TBL] [Abstract][Full Text] [Related]
24. [X-linked adrenoleukodystrophy--2 case reports].
Dumić M; Ille J; Plavsić V; Filipović-Grcić B; Vrljicak K; Barisić N; Roscher A
Lijec Vjesn; 1998; 120(1-2):19-23. PubMed ID: 9650481
[TBL] [Abstract][Full Text] [Related]
25. [Spastic paraparesis and adrenal gland insufficiency: adrenomyeloneuropathy].
Zijlmans JM; van Marion WF
Ned Tijdschr Geneeskd; 1987 Jan; 131(5):208-11. PubMed ID: 3822010
[No Abstract] [Full Text] [Related]
26. Adrenoleukodystrophy: clinical and biochemical manifestations in carriers.
O'Neill BP; Moser HW; Saxena KM; Marmion LC
Neurology; 1984 Jun; 34(6):798-801. PubMed ID: 6539445
[TBL] [Abstract][Full Text] [Related]
27. Autonomic neuropathy in a patient with adrenomyeloneuropathy.
Schulte-Mattler WJ; Lindner A; Zierz S
Eur J Med Res; 1996 Nov; 1(12):559-61. PubMed ID: 9438162
[TBL] [Abstract][Full Text] [Related]
28. Auditory brainstem response findings and peripheral auditory sensitivity in adrenoleukodystrophy.
Pillion JP; Kharkar S; Mahmood A; Moser H; Shimizu H
J Neurol Sci; 2006 Sep; 247(2):130-7. PubMed ID: 16737712
[TBL] [Abstract][Full Text] [Related]
29. [Adrenomyeloneuropathy. Report of two siblings and female heterozygote with spastic paraparesis].
Ibi T; Matsuoka Y; Sobue I; Matsui T; Tsuji S
Rinsho Shinkeigaku; 1982 Nov; 22(11):980-5. PubMed ID: 7168937
[No Abstract] [Full Text] [Related]
30. Multimodality evoked potentials in patients and carriers with adrenoleukodystrophy and adrenomyeloneuropathy.
Tobimatsu S; Fukui R; Kato M; Kobayashi T; Kuroiwa Y
Electroencephalogr Clin Neurophysiol; 1985 Jan; 62(1):18-24. PubMed ID: 2578374
[TBL] [Abstract][Full Text] [Related]
31. Identification of mutations in the ALD-gene of 20 families with adrenoleukodystrophy/adrenomyeloneuropathy.
Krasemann EW; Meier V; Korenke GC; Hunneman DH; Hanefeld F
Hum Genet; 1996 Feb; 97(2):194-7. PubMed ID: 8566952
[TBL] [Abstract][Full Text] [Related]
32. A missense point mutation (Ser515Phe) in the adrenoleukodystrophy gene in a family with adrenomyeloneuropathy: a clinical, biochemical, and genetic study.
Vorgerd M; Fuchs S; Tegenthoff M; Malin JP
J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):229-31. PubMed ID: 7876858
[TBL] [Abstract][Full Text] [Related]
33. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.
Moser AB; Borel J; Odone A; Naidu S; Cornblath D; Sanders DB; Moser HW
Ann Neurol; 1987 Mar; 21(3):240-9. PubMed ID: 2440378
[TBL] [Abstract][Full Text] [Related]
34. Therapy of X-linked adrenoleukodystrophy.
Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress is induced in female carriers of X-linked adrenoleukodystrophy.
Deon M; Sitta A; Barschak AG; Coelho DM; Terroso T; Schmitt GO; Wanderley HY; Jardim LB; Giugliani R; Wajner M; Vargas CR
J Neurol Sci; 2008 Mar; 266(1-2):79-83. PubMed ID: 17915255
[TBL] [Abstract][Full Text] [Related]
36. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy.
Moser HW; Moser AB; Naidu S; Bergin A
Dev Neurosci; 1991; 13(4-5):254-61. PubMed ID: 1817030
[TBL] [Abstract][Full Text] [Related]
37. Evoked response studies in patients with adrenoleukodystrophy and heterozygous relatives.
Garg BP; Markand ON; DeMyer WE; Warren C
Arch Neurol; 1983 Jun; 40(6):356-9. PubMed ID: 6847442
[TBL] [Abstract][Full Text] [Related]
38. Phenotype heterogeneity among hemizygotes in a family biochemically screened for adrenoleukodystrophy.
Cotrufo R; Melone MA; Monsurro MR; Di Iorio G; Carella C; Moser HW
Am J Med Genet; 1987 Apr; 26(4):833-8. PubMed ID: 3591825
[TBL] [Abstract][Full Text] [Related]
39. Adrenoleukodystrophy and variants. Clinical, neurophysiological and biochemical studies in patients and family members.
Goto I; Kobayashi T; Antoku Y; Tobimatsu S; Kuroiwa Y
J Neurol Sci; 1986 Jan; 72(1):103-12. PubMed ID: 3081689
[TBL] [Abstract][Full Text] [Related]
40. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].
Stradomska TJ; Tylki-Szymańska A
Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
